Influencing and shaping our sector BIA update: April - July 2023

The BioIndustry Association (BIA) continued to represent the innovative life science and biotech sector to ministers and senior policymakers between April and July 2023. This quarterly report provides an overview of these engagements.

In July, our twenty-third annual Parliament Day was the biggest yet, with the Science Secretary, Minister for Health, and Minister for Investment among those welcoming delegations of BIA members. Thirty stakeholder meetings with our members were held to hear about the importance of delivering growth, improving health outcomes, and innovating for the future.

The Chancellor’s announcement of the Mansion House Compact saw the culmination of years of influencing by the BIA, unlocking pension funds to invest in innovative, AIM-listed companies that will be the life science leaders of the future. Our influencing on skills also reached new heights with the launch of the #BIGIMPACT campaign, which aims to direct talent into our growing sector.

 

 

The BIA also published its vision for the next VPAS agreement, collaborated on a blueprint for the future of medicines manufacturing as part of MMIP, and welcomed the arrival of the O’Shaughnessy Review of clinical trials, helping to shape the environment for life sciences for years to come.

Read on for further details of all of the BIA’s important influencing work across our key policy areas.